Dermatology

Switching biologic treatments in dermatologyNot all biologic treatments are equal. Side effects, effectiveness, cost and administration style are among factors physicians should consider when switching treatments, experts report at AAD 2018.
Strategic planningDermatologists must be aware of pending payment reductions and actively oppose Medicare's proposed elimination of global periods for certain procedures.
Transgender careIncreasing dermatologists' cultural competence in this community can eliminate a barrier to care.
Up-and-coming fillers and neuromodulatorsInjectable aesthetic products recently FDA-approved or in late stages of development include polycaprolactone, a new hyaluronic acid and multiple neuromodulators.
Biologics offer promise for hidradenitis suppurativa treatmentWith one approved biologic available and many more under investigation, the future of treatment for hidradenitis suppurativa looks very promising.
Pityriasis rubra pilaris: biologics can helpFor some patients with pityriasis rubra pilaris (PRP) who do not respond to standard systemic treatments, biologic therapy may result in marked clinical improvement.
Managing hedgehog therapies for basal cell carcinomaWhile the vast majority of basal cell carcinomas are treated and resolved with surgery, systemic therapy with one of the two hedgehog pathway inhibitors could be a treatment option for unresectable or metastasized disease, researchers reported at the American Academy of Dermatology annual meeting in San Diego this week.
The experts weigh in on pros and cons of biologicsAccess issues due to cost and availability causes disparities in biologics use; cancer risk is minimal and there is much more on the horizon for hidradenitis suppurativa, researchers say at AAD 2018.
Atopic dermatitis: From guidelines to practiceThis week during the annual meeting of the American Academy of Dermatology in San Diego, Robert Sidbury, M.D., addressed developments in atopic dermatitis treatments since the publication of treatment guidelines in 2014.
Spironolactone for hormonal acneFemale patients with hormonal acne that typically flares before or after menstrual cycles may be ideal candidates for spironolactone, said Emmy M. Graber, M.D., president of the Dermatology Institute of Boston who spoke at AAD 2018 in San Diego this week.